NO751351L - - Google Patents

Info

Publication number
NO751351L
NO751351L NO751351A NO751351A NO751351L NO 751351 L NO751351 L NO 751351L NO 751351 A NO751351 A NO 751351A NO 751351 A NO751351 A NO 751351A NO 751351 L NO751351 L NO 751351L
Authority
NO
Norway
Application number
NO751351A
Other languages
Norwegian (no)
Other versions
NO144071C (no
NO144071B (no
Inventor
P E Aldrich
G H Berezin
B I Dittmar
Original Assignee
Du Pont
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont filed Critical Du Pont
Publication of NO751351L publication Critical patent/NO751351L/no
Publication of NO144071B publication Critical patent/NO144071B/no
Publication of NO144071C publication Critical patent/NO144071C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D331/00Heterocyclic compounds containing rings of less than five members, having one sulfur atom as the only ring hetero atom
    • C07D331/04Four-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/46Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings substituted on the ring sulfur atom
    • C07D333/48Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings substituted on the ring sulfur atom by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO751351A 1974-04-17 1975-04-16 Analogifremgangsmaate ved fremstilling av antihypertensivt aktive thienyl- og thietyl-ureaer NO144071C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46169974A 1974-04-17 1974-04-17
US05/555,307 US4009847A (en) 1974-04-17 1975-03-11 1-Tertiary-alkyl-3-(substituted thienyl)ureas and 1-tertiary-alkyl-3-(substituted thietyl)ureas as antihypertensive agents

Publications (3)

Publication Number Publication Date
NO751351L true NO751351L (en:Method) 1975-10-20
NO144071B NO144071B (no) 1981-03-09
NO144071C NO144071C (no) 1981-06-17

Family

ID=27040095

Family Applications (1)

Application Number Title Priority Date Filing Date
NO751351A NO144071C (no) 1974-04-17 1975-04-16 Analogifremgangsmaate ved fremstilling av antihypertensivt aktive thienyl- og thietyl-ureaer

Country Status (21)

Country Link
US (1) US4009847A (en:Method)
JP (1) JPS50148349A (en:Method)
AR (1) AR208545A1 (en:Method)
CA (1) CA1047042A (en:Method)
CH (1) CH611292A5 (en:Method)
DD (1) DD117223A5 (en:Method)
DE (1) DE2516554A1 (en:Method)
DK (1) DK164175A (en:Method)
ES (1) ES436648A1 (en:Method)
FI (1) FI751128A7 (en:Method)
FR (1) FR2267773B1 (en:Method)
GB (1) GB1461209A (en:Method)
HU (1) HU173052B (en:Method)
IE (1) IE41143B1 (en:Method)
IL (1) IL47095A (en:Method)
LU (1) LU72306A1 (en:Method)
NL (1) NL7504570A (en:Method)
NO (1) NO144071C (en:Method)
PH (1) PH11722A (en:Method)
SE (1) SE417965B (en:Method)
YU (1) YU96075A (en:Method)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4156738A (en) * 1977-10-07 1979-05-29 E. I. Du Pont De Nemours And Company Ureidonitriles useful as antihypertensives
US6187799B1 (en) * 1997-05-23 2001-02-13 Onyx Pharmaceuticals Inhibition of raf kinase activity using aryl ureas
US6344476B1 (en) * 1997-05-23 2002-02-05 Bayer Corporation Inhibition of p38 kinase activity by aryl ureas
US7517880B2 (en) 1997-12-22 2009-04-14 Bayer Pharmaceuticals Corporation Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas
US20080300281A1 (en) * 1997-12-22 2008-12-04 Jacques Dumas Inhibition of p38 Kinase Activity Using Aryl and Heteroaryl Substituted Heterocyclic Ureas
US7329670B1 (en) 1997-12-22 2008-02-12 Bayer Pharmaceuticals Corporation Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureas
US20080269265A1 (en) * 1998-12-22 2008-10-30 Scott Miller Inhibition Of Raf Kinase Using Symmetrical And Unsymmetrical Substituted Diphenyl Ureas
EP1140840B1 (en) 1999-01-13 2006-03-22 Bayer Pharmaceuticals Corp. -g(v)-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
US8124630B2 (en) * 1999-01-13 2012-02-28 Bayer Healthcare Llc ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
HK1042251B (en) * 1999-01-13 2012-07-20 Bayer Healthcare Llc Omega-carboxy aryl substituted diphenyl ureas as p38 kinase inhibitors
ME00275B (me) 1999-01-13 2011-02-10 Bayer Corp ω-KARBOKSIARIL SUPSTITUISANI DIFENIL KARBAMIDI KAO INHIBITORI RAF KINAZE
US7928239B2 (en) 1999-01-13 2011-04-19 Bayer Healthcare Llc Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureas
US7235576B1 (en) 2001-01-12 2007-06-26 Bayer Pharmaceuticals Corporation Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
US7371763B2 (en) * 2001-04-20 2008-05-13 Bayer Pharmaceuticals Corporation Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas
ES2275931T5 (es) * 2001-12-03 2018-10-23 Bayer Healthcare Llc Compuestos de aril-urea en combinación con otros agentes citostáticos o citotóxicos para tratamiento de cánceres humanos
US20080108672A1 (en) * 2002-01-11 2008-05-08 Bernd Riedl Omega-Carboxyaryl Substituted Diphenyl Ureas As Raf Kinase Inhibitors
CA2475703C (en) * 2002-02-11 2016-12-20 Bayer Pharmaceuticals Corporation Aryl ureas with angiogenesis inhibiting activity
US20030216396A1 (en) 2002-02-11 2003-11-20 Bayer Corporation Pyridine, quinoline, and isoquinoline N-oxides as kinase inhibitors
DK1580188T3 (da) * 2002-02-11 2012-02-06 Bayer Healthcare Llc Forbindelser af arylurea som kinaseinhibitorer
WO2003068223A1 (en) * 2002-02-11 2003-08-21 Bayer Corporation Aryl ureas with raf kinase and angiogenesis inhibiting activity
UY28213A1 (es) 2003-02-28 2004-09-30 Bayer Pharmaceuticals Corp Nuevos derivados de cianopiridina útiles en el tratamiento de cáncer y otros trastornos.
ATE366108T1 (de) * 2003-05-20 2007-07-15 Bayer Pharmaceuticals Corp Diaryl-harnstoffe für durch pdgfr vermittelte krankheiten
PL1663978T3 (pl) * 2003-07-23 2008-04-30 Bayer Healthcare Llc Fluoropodstawiony omega-karboksyarylodifenylomocznik do leczenia i profilaktyki chorób i stanów
CA2564325A1 (en) * 2004-04-30 2005-11-24 Bayer Pharmaceuticals Corporation Substituted pyrazolyl urea derivatives useful in the treatment of cancer

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH452475A (de) * 1965-05-20 1968-05-31 Bayer Ag Verfahren zum Färben und Bedrucken von synthetischem Textilmaterial mit Anthrachinonfarbstoffen

Also Published As

Publication number Publication date
GB1461209A (en) 1977-01-13
JPS50148349A (en:Method) 1975-11-27
NO144071C (no) 1981-06-17
IL47095A (en) 1978-03-10
CH611292A5 (en:Method) 1979-05-31
ES436648A1 (es) 1977-08-01
FR2267773B1 (en:Method) 1978-08-18
DD117223A5 (en:Method) 1976-01-05
SE417965B (sv) 1981-04-27
US4009847A (en) 1977-03-01
NO144071B (no) 1981-03-09
DE2516554A1 (de) 1975-10-30
DK164175A (da) 1975-10-18
AR208545A1 (es) 1977-02-15
HU173052B (hu) 1979-02-28
IE41143B1 (en) 1979-10-24
CA1047042A (en) 1979-01-23
YU96075A (en) 1983-04-27
SE7503523L (sv) 1975-10-20
PH11722A (en) 1978-05-30
NL7504570A (nl) 1975-10-21
LU72306A1 (en:Method) 1976-03-17
AU8013575A (en) 1976-10-21
IL47095A0 (en) 1975-06-25
FR2267773A1 (en:Method) 1975-11-14
FI751128A7 (en:Method) 1975-10-18
IE41143L (en) 1975-10-17

Similar Documents

Publication Publication Date Title
DK142634C (en:Method)
NO751351L (en:Method)
AU495930B2 (en:Method)
AU495821B2 (en:Method)
AU495844B2 (en:Method)
AU8191875A (en:Method)
AU7138274A (en:Method)
AU6717074A (en:Method)
AU6599874A (en:Method)
BG19727A1 (en:Method)
BG19965A1 (en:Method)
AU481953A (en:Method)
AU481597A (en:Method)
AU481516A (en:Method)
AU480758A (en:Method)
AU480399A (en:Method)
AU480187A (en:Method)
AU480148A (en:Method)
AU480070A (en:Method)
BE836964A (en:Method)
BG19628A1 (en:Method)
BG19673A1 (en:Method)
BG19712A1 (en:Method)
BG19725A1 (en:Method)
BG20641A1 (en:Method)